USER INFORMATION PAMPHLET Suero Fisiológico Vitulia 0.9% solution for perfusion Sodium chloride

Size: px
Start display at page:

Download "USER INFORMATION PAMPHLET Suero Fisiológico Vitulia 0.9% solution for perfusion Sodium chloride"

Transcription

1 USER INFORMATION PAMPHLET Suero Fisiológico Vitulia 0.9% solution for perfusion Sodium chloride Read the whole of this prospectus in detail, because it contains information that will be important to you. This medication can be obtained without a prescription for the treatment of minor afflictions without the intervention of a doctor. However, you must use Suero Fisiológico Vitulia with care to obtain the best results. -Keep this prospectus; you may need to read it again. -If you have any doubts, consult your doctor or pharmacists. This medicine has been prescribed to you and must not be given to others. It may harm them, even when their symptoms are the same as yours. In this prospectus: 1. What are Suero Fisiológico Vitulia and what are they used for? 2. Before using Suero Fisiológico Vitulia 3. How to use Suero Fisiológico Vitulia 4. Possible adverse effects 5. Storage of Suero Fisiológico Vitulia 1. WHAT IS Suero Fisiológico Vitulia AND WHAT IS IT USED FOR? Suero Fisiológico Vitulia belongs to the intravenous group of medicines. Suero Fisiológico Vitulia is used to replenish water and sodium and chloride salts that can be low as a consequence of different alterations or disorders. It is also used as a transport solution for other compatible medicines. 2. BEFORE USING Suero Fisiológico Vitulia Do not use Suero Fisiológico Vitulia - If you are allergic to (hypersensitive) the principal component of Suero Fisiológico Vitulia. If you present: - Excess water in the body (hyperhydration), excess sodium (hypernatremia) or chloride (hyperchloremia). - Acidosis (a lower ph than the normal range). - Oedematous states in patients with cardiac, hepatic or renal alterations or serious hypertension. In the same way it should not be administered to patients with low sodium levels (hypokalemia) above all in those with cardiovascular sicknesses. Be especially careful with Suero Fisiológico Vitulia

2 If you have disorders where a restriction on the consumption of sodium is indicated, such as cardiac insufficiency, generalised retention of liquids oedema, retention of liquid in the lungs, (lung oedema), hypertension (high blood pressure), hypertension during pregnancy (eclampsia), serious kidney insufficiency. Salt in serum needs to be checked regularly as does the water balance and the acid-base equilibrium. In prolonged therapies and in patients with an acid-base disequilibrium, cardiac, hepatic and/or renal alterations, or if you are being treated with corticoids or the adrenocorticotropic hormone frequent checks on the electrolytes in the blood need to be done. In the case that your suffer a case of hypertonic dehydration (loss of water with an excess of salts) a high perfusion speed needs to be avoided as it can provoke an increase in the plasma s osmolarity (concentration of salts in the plasma), and specifically, an increase in the concentration of sodium in the plasma (the quantity of sodium in the blood). In preterm infants and those breast feeding the administration of sodium chloride must only be done after determining the levels of sodium in the serum. Use of other medicines Inform your doctor or pharmacist if you are taking or have recently taken other medicines, including those acquired without prescription. The administration of sodium chloride accelerated the renal excretion of lithium, leading to its reduced therapeutic effectiveness. It must be administered with care to those being treated with corticoids or the adrenocorticotropic hormone as they can retain water and sodium. Before mixing with other medicines the compatibility tables must be checked, the ph born in mind and the ions controlled. Pregnancy and while breast feeding Consult your doctor or pharmacist before using any medicine. Suero Fisiológico Vitulia can be used when indicated during pregnancy and when breast feeding. Until now there is no relevant epidemiological data and so it is recommended that if used it be used with precaution. Driving and the use of machines This is not appropriate in the context of treatment with this medicine.

3 3. HOW TO USE Suero Fisiológico Vitulia Follow the administration instructions for Suero Fisiológico Vitulia given by your doctor exactly. Consult your doctor or pharmacist if you have doubts. The standard dose is up to 40ml per kg of body weight. The velocity of perfusion recommended is of some 5ml per kg of body weight per hour, which corresponds to 1.7 drops per kg of body weight per minute. Your doctor will decide the dose and frequency with which the solution is administered, it will depend on your age, weight and clinical situation. A greater quantity of solution must be administered and at a higher speed in those patients who manifest a deficit of plasma volume (hypovolemic shock). If you use more Suero Fisiológico Vitulia than you should It is very unlikely that this will happen as your doctor will determine your daily doses. However, if you did receive an overdose, it could provoke an excess concentration of sodium in the blood, chloride and electrolytes in general or have an excess of hydration and related manifestations like metabolic acidosis (inferior blood ph to normal), overcharging of the heart and the formation of oedemas. In such a case, the perfusion must be interrupted, and diuretic medicines administered in order to eliminate the excess liquid, as well as a check on the electrolytes in the blood and the acid-base equilibrium. If you are not checked in to hospital go to the nearest one or consult the Toxicology Information Service. Telephone: , indicating the medicine and the amount ingested. If you have any doubt about the use of this product, ask your doctor or pharmacist. 4. POSSIBLE SIDE EFFECTS As with all medicines, Suero Fisiológico Vitulia can produce side effects, though not everyone suffers them. If large quantities of the solution are administered, the levels of sodium and chloride in the plasma may increase. If it is administered continuously in the same perfusion location it can produce pain, fever, infections and phlebitis which extends from the point of injection, extravasation and hypervolaemia. If it is used as a vehicle for the administration of other drugs, the nature of the other drugs administered will determine the probability of other side effects. In the case of side effects the perfusion must be interrupted.

4 If you consider any of the side effects you suffer to be serious, or if you notice any other side effect not mentioned in this pamphlet, inform your doctor or pharmacist. 5. CONSERVATION OF Suero Fisiológico Vitulia Keep out of reach and sight of children. It does not require special conditions for its conservation. Do not use Suero Fisiológico Vitulia after the expiry date which appears on the container. The expiry date is the last day of the month indicated. Do not use Suero Fisiológico Vitulia if it is cloudy or shows sedimentation (presence of particles at the bottom of the container) or if the container shows signs of deterioration. Medicines must not be disposed of in the drains or thrown away. Leave unwanted medicines and containers at the SIGRE point in a chemist. Ask your pharmacist how to dispose of any containers or unneeded medicines. This way you will help look after the environment. 6. ADDITIONAL INFORMATION Composition of Suero Fisiológico Vitulia The principal component is: Principal component Per 100ml Sodium chloride 0.9g Electrolytes mmol/l meq/l Sodium Chlorides Theoretical osmolarity 308 mosm/l Acidity (up to ph 7.4) <0.3 mmol/l ph The other components are: water for injections. Product appearance and container contents Suero Fisiológico Vitulia is a solution for perfusion, transparent and colourless, which is presented in plastic jars (Ecoflac Plus ) of 50, 100, 250, 500 and 1000 ml (it is possible that not all sizes are commercialised). Clinical box: ml jars ml jars ml jars ml jars ml jars

5 Holder of the authorisation for the commercialisation and fabrication of the product. LABORATORIOS ERN, S.A. Pedro IV, Barcelona, España This pamphlet was revised in June This information is for doctors and health professionals only: Single use containers. Dispose of any remaining content not used after finishing the perfusion. The solution must only be used if the seal is not damaged and the solution is clear. Use the sterile administration set for its administration. Detailed and updated information about this product is available on the webpage of the Spanish Agency for Medicines and Health Products (AEMPS)

1. WHAT IS SUERO RINGER LACTATO VITULIA AND WHAT IS IT USED FOR?

1. WHAT IS SUERO RINGER LACTATO VITULIA AND WHAT IS IT USED FOR? USER INFORMATION PAMPHLET SUERO RINGER LACTATO VITULIA solution for perfusion Sodium lactate, Sodium chloride, Potassium chloride, Dehydrated calcium chloride Read the whole of this prospectus in detail,

More information

USER INFORMATION PAMPHLET SENIORAL jarabe niños Clocinizine dihydrochloride/phenylpropanolamine hydrochloride

USER INFORMATION PAMPHLET SENIORAL jarabe niños Clocinizine dihydrochloride/phenylpropanolamine hydrochloride USER INFORMATION PAMPHLET SENIORAL jarabe niños Clocinizine dihydrochloride/phenylpropanolamine hydrochloride Read the whole of this prospectus in detail, because it contains information that will be important

More information

TERBASMIN EXPECTORANTE SOLUCION

TERBASMIN EXPECTORANTE SOLUCION TERBASMIN EXPECTORANTE SOLUCION Read the whole of this prospectus in detail, because it contains information that will be important to you. This medication can be obtained without a prescription for the

More information

USER INFORMATION PAMPHLET. Metalgial 500mg/ml oral drops in solution (sodium metamizole)

USER INFORMATION PAMPHLET. Metalgial 500mg/ml oral drops in solution (sodium metamizole) USER INFORMATION PAMPHLET Metalgial 500mg/ml oral drops in solution (sodium metamizole) Read the whole of this prospectus in detail, because it contains information that will be important to you. This

More information

User Information Pamphlet Paracetamol Level 100 mg/ml oral solution EFG

User Information Pamphlet Paracetamol Level 100 mg/ml oral solution EFG User Information Pamphlet Paracetamol Level 100 mg/ml oral solution EFG Read the whole of this prospectus in detail, because it contains information that will be important to you. This medication can be

More information

User Information Pamphlet Apiretal 325/500mg Comprimidos Bucodispersables (Paracetamol)

User Information Pamphlet Apiretal 325/500mg Comprimidos Bucodispersables (Paracetamol) User Information Pamphlet Apiretal 325/500mg Comprimidos Bucodispersables (Paracetamol) Read the whole of this prospectus in detail, because it contains information that will be important to you. This

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient KLORUR NATRIUMI Solution for injection 1000 mg / 10 ml (10 %) Solution for injection 85 mg / 10 ml (0.85 %) Solution for infusion 0.9% (Sodium chloride) Read

More information

Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride

Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride Package leaflet: Information for the user Sodium Chloride 0.9% w/v Intravenous Infusion BP Solution for Infusion Sodium chloride Read all of this leaflet carefully before using this medicine because it

More information

Prospectus: User information Astenolit solución oral

Prospectus: User information Astenolit solución oral Prospectus: User information Astenolit solución oral Read the whole of this prospectus in detail, because it contains information that will be important to you. This medication can be obtained without

More information

2. What you need to know before you use Compound Sodium Lactate

2. What you need to know before you use Compound Sodium Lactate Package leaflet: Information for the user Compound Sodium Lactate Intravenous Infusion BP, Ecobag (Hartmann s Solution) Read all of this leaflet carefully before you start using this medicine because it

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate

PACKAGE LEAFLET: INFORMATION FOR THE USER. SODIPHOS 22mEq / 10ml Concentrate for solution for infusion. Disodium phosphate dihydrate PACKAGE LEAFLET: INFORMATION FOR THE USER SODIPHOS 22mEq / 10ml Concentrate for solution for infusion Disodium phosphate dihydrate Read all of this leaflet carefully before you start using this medicine.

More information

PAMPHLET : INFORMATION FOR THE USER Adrenaline Level 1mg/ml injectable solution Eponefrina

PAMPHLET : INFORMATION FOR THE USER Adrenaline Level 1mg/ml injectable solution Eponefrina PAMPHLET : INFORMATION FOR THE USER Adrenaline Level 1mg/ml injectable solution Eponefrina Please read the whole information pamphlet carefully before starting to use this medicine. - Do not throw this

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin

PACKAGE LEAFLET: INFORMATION FOR THE USER. Human Albumin Biotest 20%, solution for infusion Human albumin PACKAGE LEAFLET: INFORMATION FOR THE USER Human Albumin Biotest 20%, solution for infusion Human albumin Read this entire leaflet carefully before you start using this medicine, because it contains important

More information

Package leaflet: Information for the user

Package leaflet: Information for the user CSL Behring Package leaflet: Information for the user Alburex 5, 50 g/l, solution for infusion & Alburex 20, 200 g/l, solution for infusion Human albumin Read all of this leaflet carefully before you are

More information

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH)

COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH) COMPANY CORE PACKAGE INSERT CCPI (PI/CORE/ENGLISH) HUMAN ALBUMIN 20 % BEHRING Rev.: 05-MAR-2008 / PEI approval 26.02.08 Supersedes previous versions Rev.: 28-NOV-2007 / Adaptation to Core SPC Rev.: 02-JAN-2007

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate)

PACKAGE LEAFLET: INFORMATION FOR THE USER. Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) PACKAGE LEAFLET: INFORMATION FOR THE USER Glucose Intravenous Infusion BP 10% w/v solution for infusion Glucose (as glucose monohydrate) Read all of this leaflet carefully before you start using this medicine

More information

Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride

Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride Package leaflet: Information for the user Potassium Chloride 0.3% w/v and Sodium Chloride 0.9% w/v Solution for Infusion Potassium chloride and sodium chloride Read all of this leaflet carefully before

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes PACKAGE LEAFLET: INFORMATION FOR THE USER Nutriflex plus Solution for Infusion Amino acids / Glucose / Electrolytes Read all of this leaflet carefully. It provides a summary of information about your medicine.

More information

Hartmann s Solution. For Infusion

Hartmann s Solution. For Infusion 0xxxxx1_00_HartmannsSolution_IE_BP 07.02.2017 13:15 Seite 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Hartmann s Solution For Infusion Read all of this leaflet carefully before you start using this medicine

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex peri Solution for Infusion. Amino acids / Glucose / Electrolytes

PACKAGE LEAFLET: INFORMATION FOR THE USER. Nutriflex peri Solution for Infusion. Amino acids / Glucose / Electrolytes PACKAGE LEAFLET: INFORMATION FOR THE USER Nutriflex peri Solution for Infusion Amino acids / Glucose / Electrolytes Read all of this leaflet carefully before you start using this medicine because it contains

More information

Package leaflet: Information for the user. multibic potassium-free solution for haemodialysis/haemofiltration

Package leaflet: Information for the user. multibic potassium-free solution for haemodialysis/haemofiltration Package leaflet: Information for the user multibic potassium-free solution for haemodialysis/haemofiltration Read all of this leaflet carefully before you start using this medicine because it contains

More information

Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion

Package leaflet: Information for the user. Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion Package leaflet: Information for the user Aminoven 5% Solution for infusion Aminoven 10% Solution for infusion Aminoven 15% Solution for infusion Read all of this leaflet carefully before you start using

More information

Package leaflet: information for the user. Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration

Package leaflet: information for the user. Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration Package leaflet: information for the user Prismasol 2 mmol/l Potassium Solution for haemodialysis/haemofiltration Calcium chloride dihydrate/ magnesium chloride hexahydrate/ glucose monohydrate/ lactic

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Active substance: enoximone PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER Perfan Injection 100 mg/20 ml Concentrate for Solution for Injection Active substance: enoximone Read all of this leaflet carefully before you

More information

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR

1. WHAT OXCARBAZEPINE IS AND WHAT IT IS USED FOR PACKAGE LEAFLET: INFORMATION FOR THE USER Oxcarbazepine 150/300/600 mg Film-Coated Tablets (Oxcarbazepine) Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion

SUMMARY OF PRODUCT CHARACTERISTICS. Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Potassium Chloride 0.15% w/v & Sodium Chloride 0.9% w/v Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Potassium Chloride

More information

Package leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate.

Package leaflet: Information for the user. Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate. Package leaflet: Information for the user Nocdurna 25 microgram oral lyophilisate Nocdurna 50 microgram oral lyophilisate desmopressin Read all of this leaflet carefully before you start taking this medicine

More information

3. PHARMACEUTICAL FORM Solution for infusion. A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green.

3. PHARMACEUTICAL FORM Solution for infusion. A clear, slightly viscous liquid; it is almost colourless, yellow, amber or green. 1. NAME OF THE MEDICINAL PRODUCT Albutein 250 g/l, solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Human albumin Albutein 250 g/l is a solution containing 250 g/l of total protein of

More information

PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER

PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER Verified with regard to factual content 13.12.2011 PATIENT INFORMATION LEAFLET: INFORMATION FOR THE USER GAMMA anty-hbs 1000 Immunoglobulinum humanum hepatitidis B Human immunoglobulin against Hepatitis

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. octaplaslg mg/ml solution for infusion Human plasma proteins

PACKAGE LEAFLET: INFORMATION FOR THE USER. octaplaslg mg/ml solution for infusion Human plasma proteins PACKAGE LEAFLET: INFORMATION FOR THE USER octaplaslg 45-70 mg/ml solution for infusion Human plasma proteins Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet.

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER biosyn Arzneimittel GmbH Schorndorfer Strasse 32, 70734 Fellbach, Germany PACKAGE LEAFLET: INFORMATION FOR THE USER Selenase 100 micrograms, solution for injection (50 micrograms/ml) 100 microgram selenium

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Emerade 150 micrograms solution for injection in pre-filled pen Emerade 300 micrograms solution for injection in pre-filled pen Emerade 500 micrograms solution

More information

PRODUCT LEAFLET: USER INFORMATION HYDROCORTISONE ERFA 20 MG TABLETS. Hydrocortisone

PRODUCT LEAFLET: USER INFORMATION HYDROCORTISONE ERFA 20 MG TABLETS. Hydrocortisone PRODUCT LEAFLET: USER INFORMATION HYDROCORTISONE ERFA 20 MG TABLETS Hydrocortisone Read this leaflet carefully before you start taking this medicine; it contains important information. - Keep this leaflet.

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Aqupharm 1 (9 mg/ml) solution for injection/infusion (UK/IE) Natriumklorid Animalcare 9 mg/ml solution for injection/infusion

More information

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin

D-Gam 250 micrograms/ml. Solution for injection. human anti-d immunoglobulin Package leaflet: Information for the patient D-Gam 50 micrograms/ml D-Gam 250 micrograms/ml Solution for injection human anti-d immunoglobulin Read all of this leaflet carefully before you start using

More information

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid

Package leaflet: Information for the patient. Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid Package leaflet: Information for the patient Tranexamic Acid 100 mg/ml, Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains

More information

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride Package leaflet: Information for the user Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride Read all of this leaflet carefully before you start using this medicine because

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. CALCICLO STEROP 11 meq 10 ml Solution for injection. Dihydrated Calcium Chloride

PACKAGE LEAFLET: INFORMATION FOR THE USER. CALCICLO STEROP 11 meq 10 ml Solution for injection. Dihydrated Calcium Chloride PACKAGE LEAFLET: INFORMATION FOR THE USER CALCICLO STEROP 11 meq 10 ml Solution for injection Dihydrated Calcium Chloride Read all of this leaflet carefully before you start using this medicine because

More information

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. SPC-0095-rev02_

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. SPC-0095-rev02_ ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS SPC-0095-rev02_14.07.2011 1 1. NAME OF THE VETERINARY MEDICINAL PRODUCT B. Braun Vet Care Hartmann s Lactated Ringers Solution for infusion for cattle, horses,

More information

THORENS I.U. /ml oral drops, solution Cholecalciferol (vitamin D 3 )

THORENS I.U. /ml oral drops, solution Cholecalciferol (vitamin D 3 ) Package leaflet: Information for the user THORENS 10 000 I.U. /ml oral drops, solution Cholecalciferol (vitamin D 3 ) Read all of this leaflet carefully before you start using this medicine, because it

More information

CONSUMER MEDICINE INFORMATION LEAFLET

CONSUMER MEDICINE INFORMATION LEAFLET CONSUMER MEDICINE INFORMATION LEAFLET Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask

More information

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride

Package leaflet: Information for the user. Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride Package leaflet: Information for the user Lidocaine Hydrochloride 1% w/v Solution for Injection Lidocaine Hydrochloride Read all of this leaflet carefully before you start using this medicine because it

More information

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide) Package leaflet: Information for the patient Bumetanide 1 mg and 5 mg Tablets (bumetanide) Read all of this leaflet carefully before you start taking this medicine because it contains important information

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER PACKAGE LEAFLET: INFORMATION FOR THE USER Alfacalcidol Strides 0.25microgram Capsules, soft Alfacalcidol Strides 0.5microgram Capsules, soft Alfacalcidol Strides 1.0microgram Capsules, soft Alfacalcidol

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan

PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan PACKAGE LEAFLET: INFORMATION FOR THE USER Irbea 75 mg film-coated tablets Irbesartan Read all of this leaflet carefully before you start taking this medicine because it contains important information for

More information

Package leaflet: Information for the user. Atosiban SUN 37.5 mg/5 ml concentrate for solution for infusion atosiban

Package leaflet: Information for the user. Atosiban SUN 37.5 mg/5 ml concentrate for solution for infusion atosiban Package leaflet: Information for the user Atosiban SUN 37.5 mg/5 ml concentrate for solution for infusion atosiban Read all of this leaflet carefully before you are given this medicine because it contains

More information

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 )

THORENS I.U. /2.5 ml oral solution. Cholecalciferol (vitamin D 3 ) Package leaflet: Information for the user THORENS 25 000 I.U. /2.5 ml oral solution Cholecalciferol (vitamin D 3 ) Read all of this leaflet carefully before you start using this medicine, because it contains

More information

Package leaflet: Information for the patient. Metformin Actavis 500 mg and 850 mg filmcoated tablets. metformin hydrochloride

Package leaflet: Information for the patient. Metformin Actavis 500 mg and 850 mg filmcoated tablets. metformin hydrochloride Package leaflet: Information for the patient Metformin Actavis 500 mg and 850 mg filmcoated tablets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine because

More information

Sodium Chloride 0.9% w/v Intravenous Infusion BP

Sodium Chloride 0.9% w/v Intravenous Infusion BP PACKAGE LEAFLET: INFORMATION FOR THE USER Sodium Chloride 0.9% w/v Intravenous Infusion BP Active substance: sodium chloride Read all of this leaflet carefully before you are given this medicine because

More information

Sodium Chloride 0.9% Injection, FK Std.

Sodium Chloride 0.9% Injection, FK Std. Text for Prescribing Information: Sodium Chloride 0.9% Injection, FK Std. DESCRIPTION Sodium Chloride 0.9% Injection is a sterile nonpyrogenic intravenous solution that contains no bacteriostatic or antimicrobial

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER. Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid PACKAGE LEAFLET: INFORMATION FOR THE USER Zoledronic Acid IBIGEN 4 mg powder and solvent for solution for infusion Zoledronic acid Read all of this leaflet carefully before you are given Zoledronic Acid

More information

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate

Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate PACKAGE LEAFLET 1 Package leaflet: Information for the user Phosex 1000 mg Tablets Calcium acetate Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

0.45% Sodium Chloride Injection, USP

0.45% Sodium Chloride Injection, USP PRESCRIBING INFORMATION 0.45% Sodium Chloride Injection, USP IV Fluid and Electrolyte Replenisher Baxter Corporation Mississauga, Ontario L5N 0C2 Canada Date of Revision: November 22, 2013 Submission Control

More information

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

SUMMARY OF PRODUCT CHARACTERISTICS 2. QUALITATIVE AND QUANTITATIVE COMPOSITION SUMMARY OF PRODUCT CHARACTERISTICS PRODUCT SUMMARY 1. NAME OF THE MEDICINAL PRODUCT Sterile Potassium Chloride Concentrate 15%. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 15% of Potassium Chloride in

More information

Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid

Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid Package leaflet: Information for the patient Tranexamic acid 100 mg/ml Solution for Injection tranexamic acid Read all of this leaflet carefully before you are given this medicine because it contains important

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Rhesonativ 750 IU/ml, solution for injection Human anti-d immunoglobulin Read all of this leaflet carefully before you start taking this medicine because it contains

More information

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER

LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER LEUCOVORIN-TEVA 10 mg/ml CONCENTRATE FOR SOLUTION FOR INFUSION folinic acid as the calcium salt PACKAGE LEAFLET: INFORMATION FOR THE USER Read all of this leaflet carefully before you start using this

More information

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin

Package leaflet: Information for the patient. NEGABAN 1g, powder for solution for injection or infusion Temocillin Package leaflet: Information for the patient NEGABAN 1g, powder for solution for injection or infusion Temocillin Read all of this leaflet carefully before you start using this medicine because it contains

More information

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol

Patient leaflet: Information for the user. Paracetamol Galpharm 500mg tablets paracetamol Patient leaflet: Information for the user Paracetamol Galpharm 500mg tablets paracetamol [For medicines available only on prescription:] Read all of this leaflet carefully before you start taking this

More information

PRODUCT INFORMATION. NAME OF THE MEDICINE Compound Sodium Lactate (Hartmann's) Solution for Injection

PRODUCT INFORMATION. NAME OF THE MEDICINE Compound Sodium Lactate (Hartmann's) Solution for Injection PRODUCT INFORMATION NAME OF THE MEDICINE Compound Sodium Lactate (Hartmann's) Solution for Injection DESCRIPTION Molecular formulae. Potassium chloride: KCl; sodium chloride: NaCl; calcium chloride dihydrate:

More information

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Package Leaflet: Information for the user LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost Read all of this leaflet carefully before you start using this medicine because it

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion

SUMMARY OF PRODUCT CHARACTERISTICS. Synthamin 14, 8.5% Amino Acid Intravenous Infusion SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Synthamin 14, 8.5% Amino Acid Intravenous Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION L-Leucine Ph. Eur 0.620% w/v L-Isoleucine

More information

Package leaflet: Information for the patient

Package leaflet: Information for the patient Package leaflet: Information for the patient UK Rocaltrol 0.25 microgram Capsules Rocaltrol 0.5 microgram Capsules Calcitriol Roche Read all of this leaflet carefully before you start taking this medicine

More information

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets

Ca-C 1000 Calvive 1000 mg mg mg effervescent tablets PACKAGE LEAFLET: INFORMATION FOR THE USER Ca-C 1000 Calvive 1000 mg + 327 mg + 1000 mg effervescent tablets CALCIUM LACTATE GLUCONATE, CALCIUM CARBONATE, ASCORBIC ACID (VITAMIN C) This leaflet is a copy

More information

Aminosteril N-Hepa 8%, solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Aminosteril N-Hepa 8%, solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Title Page Information Aminosteril N-Hepa 8% November 2001 1 (7) 1. NAME OF THE MEDICINAL PRODUCT Aminosteril N-Hepa 8%, solution for infusion. 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1000 ml solution

More information

Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite

Package leaflet: Information for the patient. Selenium 10 micrograms/ml concentrate for solution for infusion. Sodium selenite Package leaflet: Information for the patient Selenium 10 micrograms/ml concentrate for solution for infusion Sodium selenite Read all of this leaflet carefully before you start using this medicine because

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lidokain Isdin 40 mg/g cream. Lidocaine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lidokain Isdin 40 mg/g cream. Lidocaine PACKAGE LEAFLET: INFORMATION FOR THE USER Lidokain Isdin 40 mg/g cream Lidocaine Read all of this leaflet carefully before you start taking this medicine. - Keep this leaflet. You may need to read it again.

More information

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex

Package leaflet: Information for the user. Bridion 100 mg/ml solution for injection sugammadex Package leaflet: Information for the user Bridion 100 mg/ml solution for injection sugammadex Read all of this leaflet carefully before you are given this medicine because it contains important information

More information

SUMMARY OF PRODUCT CHARACTERISTICS. Flexbumin 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin.

SUMMARY OF PRODUCT CHARACTERISTICS. Flexbumin 200 g/l is a solution containing 200 g/l (20%) of total protein of which at least 95% is human albumin. SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Flexbumin 200g/l solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Flexbumin 200 g/l is a solution containing 200 g/l

More information

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops

PATIENT INFORMATION LEAFLET. PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Page 1 of 6 SCHEDULING STATUS Schedule 4 PATIENT INFORMATION LEAFLET PROPRIETARY NAME, STRENGTH AND PHARMACEUTICAL FORM LUMIGAN 0,01 %, bimatoprost 0,1 mg/ml eye drops Read all of this leaflet carefully

More information

Package leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration

Package leaflet: Information for the user. HEPATECT CP 50 IU/ml solution for infusion. Human hepatitis B immunoglobulin for intravenous administration : Information for the user HEPATECT CP 50 IU/ml solution for infusion Human hepatitis B immunoglobulin for intravenous administration Read all of this leaflet carefully before you start using this medicine

More information

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human)

PATIENT / USER INFORMATION LEAFLET. Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human) PATIENT / USER INFORMATION LEAFLET Cinryze 500 Units powder and solvent for solution for injection C1 inhibitor (human) Read all of this leaflet carefully before you start taking this medicine. Keep this

More information

Patient Information Leaflet: Information for users

Patient Information Leaflet: Information for users Unofficial translation of the German package leaflet Patient Information Leaflet: Information for users Medivitan im with lidocaine, solution for injection Pre-filled syringe Ampoules Active substances:

More information

1. What Miacalcic is and what it is used for

1. What Miacalcic is and what it is used for Package leaflet: Information for the user Miacalcic 100 IU/ml solution for injection and infusion Calcitonin (salmon, synthetic) Read all of this leaflet carefully before you start using this medicine

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Pneumococcal Polysaccharide Vaccine PACKAGE LEAFLET: INFORMATION FOR THE USER PNEUMOVAX 23 solution for injection in a vial Pneumococcal Polysaccharide Vaccine For adults and children 2 years and above. Read all of this leaflet carefully

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion

PACKAGE LEAFLET: INFORMATION FOR THE USER. Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion PACKAGE LEAFLET: INFORMATION FOR THE USER Cisatracurium 2 mg/ml solution for injection/infusion Cisatracurium 5 mg/ml solution for injection/infusion Cisatracurium Read all of this leaflet carefully before

More information

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol) Package leaflet: Information for the user Colecalciferol 3000 IU/ml Oral Solution (colecalciferol) Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Read all of this leaflet carefully before you start using this medicine.

Read all of this leaflet carefully before you start using this medicine. PACKAGE LEAFLET: INFORMATION FOR THE USER Allergo-COMOD nasal spray 20 mg/ml Nasal spray, solution Active ingredient: sodium cromoglicate (Ph. Eur.) 1 spray of 0.14 ml of Allergo-COMOD nasal spray contains

More information

Package leaflet: Information for the user. Paralink 10 mg/ml Solution for Infusion Paracetamol

Package leaflet: Information for the user. Paralink 10 mg/ml Solution for Infusion Paracetamol Package leaflet: Information for the user Paralink 10 mg/ml Solution for Infusion Paracetamol Read all of this leaflet carefully before you are given this medicine because it contains important information

More information

SUMMARY OF PRODUCT CHARACTERISTICS mg (6.85 mg)

SUMMARY OF PRODUCT CHARACTERISTICS mg (6.85 mg) SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Aminoplasmal B. Braun 10% E Solution for Infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION The solution for infusion contains: per

More information

Package leaflet: Information for the user. GLUCOPHAGE 500 mg powder for oral solution in sachets metformin hydrochloride

Package leaflet: Information for the user. GLUCOPHAGE 500 mg powder for oral solution in sachets metformin hydrochloride Package leaflet: Information for the user GLUCOPHAGE 500 mg powder for oral solution in sachets metformin hydrochloride Read all of this leaflet carefully before you start taking this medicine - Keep this

More information

AVIOMARIN 50 mg tablets

AVIOMARIN 50 mg tablets PACKAGE LEAFLET: INFORMATION FOR THE USER AVIOMARIN 50 mg tablets DIMENHYDRINATE This leaflet is a copy of the Summary of Product Characteristics and Patient Information Leaflet for a medicine, which outlines

More information

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate

Package leaflet: Information for the user. Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate Package leaflet: Information for the user Bricanyl Respules 2.5 mg/ml Nebuliser Solution terbutaline sulfate Read all of this leaflet carefully before you start using this medicine because it contains

More information

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime

Package leaflet: Information for the user. Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Package leaflet: Information for the user Cefixime ABR 100 mg/5 ml powder for oral suspension Cefixime Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Some general information on hepatitis A infection is given at the end of this leaflet.

Some general information on hepatitis A infection is given at the end of this leaflet. Package Leaflet: Information for the User Havrix Monodose Vaccine Suspension for injection in a pre-filled syringe Hepatitis A (inactivated) vaccine (adsorbed) Read all of this leaflet carefully before

More information

Package leaflet: Information for the user

Package leaflet: Information for the user 8U004E Package leaflet: Information for the user DT Diphtheria-tetanus vaccine adsorbed suspension for injection Diphtheria and tetanus vaccine, adsorbed Tetanus toxoid not less than 40 IU and diphtheria

More information

IMOVAX POLIO POLIOMYELITIS VACCINE (INACTIVATED) Suspension for injection in prefilled syringe

IMOVAX POLIO POLIOMYELITIS VACCINE (INACTIVATED) Suspension for injection in prefilled syringe IMOVAX POLIO POLIOMYELITIS VACCINE (INACTIVATED) Suspension for injection in prefilled syringe Read all of this leaflet carefully before you are vaccinated or before you have your child vaccinated. Keep

More information

PACKAGE LEAFLET: Information for the user. METFORMINE Film-coated tablets 500 mg, 850 mg or 1000 mg (Metformin hydrochloride)

PACKAGE LEAFLET: Information for the user. METFORMINE Film-coated tablets 500 mg, 850 mg or 1000 mg (Metformin hydrochloride) PACKAGE LEAFLET: Information for the user METFORMINE Film-coated tablets 500 mg, 850 mg or 1000 mg (Metformin hydrochloride) Read this leaflet carefully before you start taking this medicine. - Keep this

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets. Betahistine dihydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Histabentine 8 mg/16 mg tablets Betahistine dihydrochloride Read all of this leaflet carefully before you start taking this medicine. Keep this leaflet. You may

More information

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000

Package leaflet: Information for the user. <PRODUCT NAME> 10 g powder for oral solution in sachet Macrogol 4000 Package leaflet: Information for the user 10 g powder for oral solution in sachet Macrogol 4000

More information

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Package leaflet: Information for the user PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Ventolin Injection 500 micrograms/ml salbutamol sulfate

Ventolin Injection 500 micrograms/ml salbutamol sulfate Package leaflet: Information for the user Ventolin Injection 500 micrograms/ml salbutamol sulfate Read all of this leaflet carefully before you start taking this medicine because it contains important

More information

Package leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin

Package leaflet: Information for the patient. Trasylol 10,000 KIU/ml solution for injection or infusion. Aprotinin Package leaflet: Information for the patient Trasylol 10,000 KIU/ml solution for injection or infusion Aprotinin Read all of this leaflet carefully before you are given this medicine because it contains

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Lartruvo 10 mg/ml concentrate for solution for infusion olaratumab This medicine is subject to additional monitoring. This will allow quick identification of new

More information

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone Read all of this leaflet carefully before you start using this medicine. - Keep this leaflet. You

More information

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride

Pilocarpine 2% w/v Eye Drops, solution. Pilocarpine 4% w/v Eye Drops, solution. Pilocarpine Hydrochloride PACKAGE LEAFLET: INFORMATION FOR THE USER Pilocarpine 2% w/v Eye Drops, solution Pilocarpine 4% w/v Eye Drops, solution Pilocarpine Hydrochloride (Referred to as Pilocarpine Eye Drops in this leaflet)

More information

Package leaflet: Information for the user

Package leaflet: Information for the user Package leaflet: Information for the user Irbesartan 75mg Film-coated Tablets Irbesartan 150mg Film-coated Tablets Irbesartan 300mg Film-coated Tablets irbesartan Read all of this leaflet carefully before

More information

Summary of Product Characteristics

Summary of Product Characteristics 1 NAME OF THE MEDICINAL PRODUCT Hartmann's Solution Compound Sodium Lactate Intravenous Infusion BP Summary of Product Characteristics 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1000 ml contains :

More information

2. PRESCRIPTION STATUS/RESTRICTION OF SALES TO PHARMACIES ONLY 3. COMPOSITION OF THE MEDICINAL PRODUCT ml of the solution for infusion contain:

2. PRESCRIPTION STATUS/RESTRICTION OF SALES TO PHARMACIES ONLY 3. COMPOSITION OF THE MEDICINAL PRODUCT ml of the solution for infusion contain: Title Page Information June 1999 1 (5) Aminoven infant 10% 1. NAME OF THE MEDICINAL PRODUCT Aminoven infant 10% 2. PRESCRIPTION STATUS/RESTRICTION OF SALES TO PHARMACIES ONLY For sale in pharmacies only

More information